Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Which AI Route are you on?

    High-Risk AI: What Road Are You On?

    The European Commission’s newly released draft guidelines (May 2026)...
    Read More

    Refresh of ANDA Approval Letters? New Guidance on ANDA Post-Approval Changes

    On June 4th, the FDA issued a guidance document titled Certain Postapp...
    Read More

    Unofficial May 2026 Approval Actions

    As we noted in the May mid-month blog report (here), the May approval ...
    Read More
    Supreme Court to Hear Skinny Label Case - Lachman Blog 2

    The Supreme Court Ruling Gives the “Skinny Label” Life to Fight Another Day

    In what these days appears to be highly unusual, a 9-0 ruling by the j...
    Read More
    If a Product Is Found to Be Safe, Should We Just Forget About Efficacy? Not On My Watch!

    If a Product Is Found to Be Safe, Should We Just Forget About Efficacy? Not On My Watch!

    On June 2, 2026 in The Wall Street Journal, Charles L. Hooper and Da...
    Read More
    Four Years of Warnings and Yet- Another Just Published

    Four Years of Warnings and Yet- Another Just Published

    Over the last week, the FDA issued a series of seven warnings about su...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today